Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy Evaluation of Supine Daoyin in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Multi-center, Randomized Controlled Trial

NCT04913961 is registered in ClinicalTrials.gov with Henan University of Traditional Chinese Medicine as lead sponsor.

NCT NCT04913961
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04913961 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy Evaluation of Supine Daoyin in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Multi-center, Randomized Controlled Trial
Lead sponsor
Henan University of Traditional Chinese Medicine
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2021
Completion date
December 31, 2023
Enrollment
228 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease